Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tonix Pharm Hldg (TNXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,298
  • Shares Outstanding, K 1,529
  • Annual Sales, $ 0 K
  • Annual Income, $ -21,120 K
  • 60-Month Beta 1.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -8.80
  • Growth Rate Est. (year over year) +11,452.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.73 +59.04%
on 03/06/19
4.20 -34.49%
on 03/08/19
+0.81 (+41.82%)
since 02/19/19
3-Month
1.70 +61.85%
on 01/31/19
4.20 -34.49%
on 03/08/19
+0.36 (+14.88%)
since 12/19/18
52-Week
1.70 +61.85%
on 01/31/19
51.10 -94.62%
on 06/07/18
-30.75 (-91.79%)
since 03/19/18

Most Recent Stories

More News
Tonix Pharmaceuticals to Participate at Upcoming Investor Conferences

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Company management will participate and host investor meetings at the following two investor conferences:

TNXP : 2.74 (-2.49%)
Tonix Pharmaceuticals Enrolls First Participant in the "RECOVERY" Study -- a New Phase 3 Trial of Tonmya(R) for the Treatment of Posttraumatic Stress Disorder

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat serious neuropsychiatric conditions...

TNXP : 2.74 (-2.49%)
Thinking about buying stock in Canopy Growth Co., Goldcorp Inc., Seelos Therapeutics Inc., Tonix Pharma Corp., or Trovagene Inc.?

InvestorsObserver issues critical PriceWatch Alerts for CGC, GG, SEEL, TNXP, and TROV.

GG : 10.98 (+1.95%)
TNXP : 2.74 (-2.49%)
Tonix Pharmaceuticals Announces New European Use Patent for TNX-601

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat serious neuropsychiatric conditions...

TNXP : 2.74 (-2.49%)
Tonix Pharmaceuticals Provides Update on Tonmya(R) for the Treatment of Posttraumatic Stress Disorder

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat serious neuropsychiatric conditions...

TNXP : 2.74 (-2.49%)
Tonix Pharmaceuticals Announces Share Repurchase Program

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced that its Board of Directors has approved a share repurchase program pursuant to which the Company may repurchase...

TNXP : 2.74 (-2.49%)
Tonix Pharmaceuticals Announces New Board Member, James Treco

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced the appointment of James Treco to its Board of Directors, effective immediately. Mr. Treco assumes the seat held...

TNXP : 2.74 (-2.49%)
Tonix Pharmaceuticals to Present at BIO CEO & Investor Conference

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present a company overview at the...

TNXP : 2.74 (-2.49%)
Tonix Pharmaceuticals to Present at Upcoming Investor Conferences and Participate in Featured Panel Discussion

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present a company overview at two...

TNXP : 2.74 (-2.49%)
Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat serious neuropsychiatric conditions...

TNXP : 2.74 (-2.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators are in flux.

See More Share

Trade TNXP with:

Business Summary

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102,...

See More

Key Turning Points

2nd Resistance Point 3.11
1st Resistance Point 2.96
Last Price 2.73
1st Support Level 2.63
2nd Support Level 2.45

See More

52-Week High 51.10
Fibonacci 61.8% 32.23
Fibonacci 50% 26.40
Fibonacci 38.2% 20.57
Last Price 2.73
52-Week Low 1.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar